NCT00821821 - Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Acute Ischemic Stroke (AIS)

Interventions

DRUG

MCI-186

"Cohort 1: Edaravone: circa 1000 mg / 72-hour infusion~Cohort 2: Edaravone: circa 2000 mg / 72-hour infusion"

DRUG

Placebo

"Cohort1:circa 1000mg / 72-hour infusion matching placebo~Cohort2:circa 2000mg / 72-hour infusion matching placebo"

Trial Locations (3)

Helsinki University Central Hospital, Helsinki

Erasmus Medical Center, Rotterdam

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle